Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nanchen

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Atherosclerosis|February 1, 2021
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse eventsRoland Klingenberg, Soheila Aghlmandi, Baris Gencer, et al.
European Heart Journal|December 25, 2016
Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarctionPhilipp Jakob, Tim Kacprowski, Sylvie Briand-Schumacher, et al.
International Journal of Cardiology|June 11, 2018
Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromesBarbara E Stähli, Manfred B Wischnewsky, Philipp Jakob, et al.
European Journal of Preventive Cardiology|March 23, 2021
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelinesKonstantinos C Koskinas, Baris Gencer, David Nanchen, et al.
European Heart Journal. Acute Cardiovascular Care|April 21, 2017
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohortSoheila Aghlmandi, Nadine Schärer, Dik Heg, et al.
Atherosclerosis Plus|January 16, 2023
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
European Heart Journal. Acute Cardiovascular Care|March 30, 2023
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onsetMiklos Rohla, Fabrice Temperli, George C M Siontis, et al.
Journal of Clinical Medicine|July 21, 2019
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary SyndromesNicolas Vuilleumier, Sabrina Pagano, Christophe Combescure, et al.
European Heart Journal. Acute Cardiovascular Care|May 20, 2021
Improving 1-year mortality prediction in ACS patients using machine learningSebastian Weichwald, Alessandro Candreva, Rebekka Burkholz, et al.
European Heart Journal. Acute Cardiovascular Care|December 10, 2020
Prognostic role of plasma galectin-3 levels in acute coronary syndromeSlayman Obeid, Nooraldaem Yousif, Allan Davies, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Atherosclerosis|February 1, 2021
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse eventsRoland Klingenberg, Soheila Aghlmandi, Baris Gencer, et al.
European Heart Journal|December 25, 2016
Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarctionPhilipp Jakob, Tim Kacprowski, Sylvie Briand-Schumacher, et al.
International Journal of Cardiology|June 11, 2018
Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromesBarbara E Stähli, Manfred B Wischnewsky, Philipp Jakob, et al.
European Journal of Preventive Cardiology|March 23, 2021
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelinesKonstantinos C Koskinas, Baris Gencer, David Nanchen, et al.
European Heart Journal. Acute Cardiovascular Care|April 21, 2017
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohortSoheila Aghlmandi, Nadine Schärer, Dik Heg, et al.
Atherosclerosis Plus|January 16, 2023
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
European Heart Journal. Acute Cardiovascular Care|March 30, 2023
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onsetMiklos Rohla, Fabrice Temperli, George C M Siontis, et al.
Journal of Clinical Medicine|July 21, 2019
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary SyndromesNicolas Vuilleumier, Sabrina Pagano, Christophe Combescure, et al.
European Heart Journal. Acute Cardiovascular Care|May 20, 2021
Improving 1-year mortality prediction in ACS patients using machine learningSebastian Weichwald, Alessandro Candreva, Rebekka Burkholz, et al.
European Heart Journal. Acute Cardiovascular Care|December 10, 2020
Prognostic role of plasma galectin-3 levels in acute coronary syndromeSlayman Obeid, Nooraldaem Yousif, Allan Davies, et al.
Pageof 14